Fda slaps sun pharma with warning letter on indian plant. Sun pharmas halol unit receives uk regulators clearance. Sun pharma gets usfda warning letter on halol facility livemint. Sun pharma receives warning letter for halol facility. While the plant was served warning letter by us regulator in december 2015, product approvals were frozen in september 2014. But new launches were cut off when the fda in 2015 vilified the plant in a warning letter. Sun pharmaranbaxy deal gets noobjection from bse, nse. Indian pharma under pressure with us fda warning letters. Our bureau mumbai updated on march 12, 2018 published on may 21, 2014. Twentyseven 27, 54% of the total, were issued to compounding pharmacies, all located in the us. Sun pharma says usfda issues at halol over, two specialty. Reddys warning letter srikakulam, ap api 6nov15 x na dr. Sun says halol plant cited again by the fda fiercepharma. The warning letter from the usfda will add to the troubles being faced by sun pharma, which has also been weighed down by the integration process with ranbaxy laboratories.
Mar 12, 2018 sun pharma gets warning letter from usfda. Sun pharmaceutical industries shares sink on fda warning letter. Sun pharma receives warning letter for halol facility mumbai, december 19, 2015. The ranbaxy acquisition will also drag margins initially though it is expected to bring benefits of scalability in the long run. The fda said in its warning letter from earlier this month, which comes as sun has also been issued an import alert over cgmp issues, that sun is missing fundamental raw data and information necessary to document its analyses. Us regulator warns sun pharma for violating manufacturing. Read more about sun pharma says usfda issues at halol over, two specialty drugs may get nod on business standard. Dec 21, 2015 fda slaps sun pharma with warning letter on indian plant. Jun 12, 2018 the agency concluded that the inspection is now closed and the issues contained in the warning letter issued in december 2015 have been addressed, sun said in a statement. For sun, the 2015 warning letter has weighed on sales and added remediation costs as the drugmaker has worked to address the fdas. Sun pharma gets us fda warning for manufacturing lapses. Dilip shangvi, managing director, expressed consternation that the warning letter, received on friday, had been sent so long after the september 2014 inspection, as he said sun had been working. Jan 05, 2016 by pharma news dcat publisher january 5, 2016 the us food and drug administration fda has issued a warning letter to sun pharmaceutical industries ltd. Sun pharma finally free of fda restrictions on its key plant in india.
If you need help accessing information in different file formats, see instructions for downloading. Dec 19, 2015 dilip shangvi, managing director, expressed consternation that the warning letter, received on friday, had been sent so long after the september 2014 inspection, as he said sun had been working. In an email to et, sun pharma shared the response that it had sent to stock exchanges when it received the form 483 warning letter after the regulator conducted inspections between february 1023. Us fda warns sun pharma for violating manufacturing standards. Corporate participants dilip shanghvi managing director, sun. Warning letter for halol facility call transcript 06. Company fda action unit nature of facility date of action date of resolution resolution in months dr. The indian drugmaker reported pdf over the weekend that an inspection from dec. Close out letter 3716 more in 2015 page last updated. Sun pharma and ranbaxy to merge, create giant pharma co we had managed to get our hands on the warning letter issued by us fda late last year. Sun pharma gets usfda warning letter on halol facility.
Matters described in fda warning letters may have been subject to subsequent interaction between fda and the letter recipient that may have changed the regulatory status of issues discussed in the letter. Sun pharma gets warning letter from usfda newsgram. The agency concluded that the inspection is now closed and the issues contained in the warning letter issued in december 2015 have been addressed, sun said in a statement. Sun pharma warns new normal will push down its sales next. Sun pharmaceuticals factory in halol, in the western indian state of gujarat, received a warning letter from the fda, the latest setback for indias pharmaceutical companies. The form 483 notice sent by us food and drug administration to sun pharma could shave off indias biggest drugmakers fy18 eps by 26%, analysts estimate the us fda issued the notice on tuesday with nine inspectional observations after an onsite inspection of sun pharmas halol facility in gujar. Sun pharma has finally dug itself out from under the issues piled on it in a 2015 warning letter at this generics plant in gujarat, india. From september 819, 2014, investigators from the u. When contacted on phone, sun pharma spokesperson declined to comment.
Indias largest drug maker sun pharma has received a warning letter from the us fda for manufacturing lapses at its facility in halol. The merger will help sun pharma to enhance its presence in emerging pharma markets like russia, brazil, south africa and also for better brand building. Us fda descends on sun pharmas halol unit business. Inspections, compliance, enforcement, and criminal investigationsranbaxy laboratories, ltd.
The fda has issued a warning letter to sun pharmaceutical for its. The problem dates back to 2014, when sun first received an fda form 483 for the site, followed shortly thereafter with a formal warning letter, citing serious sterility concerns. Fda finds incomplete lab records at sun pharma plant. Fda issued 50 drug gmp warning letters in calendar year 2015. View sun pharmaceutical industries limiteds fda inspection, warning letter, form 483 observation details related to gmp quality systems on. Feb 23, 2018 but new launches were cut off when the fda in 2015 vilified the plant in a warning letter. Apr 21, 2017 sun pharmas stock fell as much as 3 percent to 636. A recently posted warning letter, issued to the pennsylvania site, mentions that sun pharmas quality unit, at the time, had knowingly released 27 lots of various strengths of clonidine hcl tablets, despite evidence that the active pharmaceutical ingredient api used in manufacturing was potentially contaminated.
The inspection lasted 12 days from the 8 th september to the 19 th september, 2014 while the warning letter was issued only in december, 2015 a complete year later as there were. Also get sun pharma adv sharestock detailed information on sun pharma adv along with top stories and articles on sun pharma adv during. In may, sun pharma s another manufacturing facility in karkhadi, also in gujarat, had received a warning letter from the us fda after investigators identified violations of current good manufacturing practice and regulations for finished pharmaceuticals. By pharma news dcat publisher january 5, 2016 the us food and drug administration fda has issued a warning letter to sun pharmaceutical industries ltd. Get latest sun pharma adv newsupdates and resultsanalysis. Food and drug administration fda inspected your pharmaceutical manufacturing facility, sun. Draft letter of offer september 15, 2015 for our equity shareholders only sun pharma advanced research company limited our company was incorporated on march 1, 2006 as sun pharma advanced research company limited under the provisions of the companies act, 1956 having.
Details of merger in april 2014 the sun pharma took over ranbaxy the deal was set at us 4. The fda has issued a warning letter to sun pharmaceutical for its plant in halol, india, a facility. Inspections, compliance, enforcement, and criminal investigations. Briefzhejiang hisun pharma receives warning from u. Sun pharmaceuticals halol plant has a history of regulatory.
The warning letter even led the fda in 2015 to revoke approval of a new. Sun house, 201 b1, western express highway, goregaon e, mumbai 400063 for further updates and specific queries, please visit. Indias largest drugmaker said on saturday it had received a letter from the fda and. Issues at sun pharmas halol plant may take 34 months to resolve. Ranbaxys stronghold in the fast growing emerging markets 50% of ranbaxys sales will complement suns presence in this space. Inspections, compliance, enforcement, and criminal. Sun pharma hit with warning letter over data issues.
Clearance of the warning letter may require another inspection, sun pharmas shanghvi said on the call. A reinspection in late 2016 was unable to lift the stigma. Sun pharma gets warning letter from usfda for key facility at. Drugmaker sun pharma says halol plant has gained u. Sun pharmas issues with halol was started in 2015, as the fda issued a warning letter subsequent to an inspection in september 2014.
Dec 17, 2015 from september 819, 2014, investigators from the u. Fda issues warning letter to recently sold sun pharma. Sun pharma gets reprieve as fda clears key halol plant. Sun pharma also said that its board has decided to evaluate a proposal for buyback of equity shares and will hold a meeting on june 23 for the purpose. Dec 21, 2015 sun pharmaceutical shares fell as much as 7. Sun pharma gets warning letter from usfda the hindu. During 2015, us fda issued 17 warning letter against 7 in the 2014 and major companies like dr reddys laboratories, cadila healthcare, sun pharmaceutical, unimark remedies, micro laboratories were recipient of warning letters or import alerts during 2015. The warning to sun pharma is the latest in a series of fda actions over the past year against drug manufacturing plants in india, which supply about 40 per cent of the medicines sold in the united. The warning to sun pharma is the latest in a series of fda actions over the past year against drug manufacturing plants in india, which supply.
At the conclusion of the inspection, the agency issued a form 483, with three observations. Dec 21, 2015 sun pharma shares fall 7% after fda warning. Press release sun pharma receives warning letter for halol. Says receives warning letter from fda over insufficient data on 29 of its active pharmaceutical ingredients api. In may, sun pharmas another manufacturing facility in karkhadi, also in gujarat, had received a warning letter from the us fda after investigators identified violations of current good manufacturing practice and regulations for finished pharmaceuticals. Sun pharmas stock fell as much as 3 percent to 636. Sun pharma subsidiary receives fda warning letter 1 min read. Food and drug administration fda inspected your pharmaceutical manufacturing facility, sun pharmaceutical industries ltd. Reddys warning letter miryalaguda, tl api 6nov15 x na. The fda in its letter dated january 15, 2017 to fleming laboratories, a pharma company in the business of manufacturing and supply of high quality generic active pharmaceutical ingredients apis to the global pharmaceutical industry observed that it has completed an evaluation of the firms corrective actions in response to its warning letter. May 26, 2017 clearance of the warning letter may require another inspection, sun pharmas shanghvi said on the call. Sep 11, 2015 says receives warning letter from fda over insufficient data on 29 of its active pharmaceutical ingredients api.
The form 483 notice sent by us food and drug administration to sun pharma could shave off indias biggest drugmakers fy18 eps by 26%, analysts estimate the us fda issued the notice on tuesday with nine inspectional observations after an. Thanks to a slew of quality control problems at one of its key generic manufacturing plants, indias largest drug maker has been under supply restrictions. Tell a friend print home sun pharma receives warning letter for halol facility. Dec 19, 2015 the warning to sun pharma is the latest in a series of fda actions over the past year against drug manufacturing plants in india, which supply about 40 per cent of the medicines sold in the united. Sun pharmaceutical industries limited fda inspections. Press release sun pharma receives warning letter for halol facility. Indias largest drugmaker sun pharma gets warning letter from.
1318 914 1591 1205 1636 1527 886 686 1510 241 267 1222 984 808 1449 1378 549 262 74 156 1278 1336 452 1095 1448 1284 301 102 816 893 487 602 1582 292 1027 454 107 657 916 119 809 289